Dr. Guangwen Yuan 袁光文
Chief Physician, Associate Professor
Department of Gynecologic Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of cervical, ovarian, and endometrial cancers. Expertise includes surgery, chemotherapy, radiotherapy, comprehensive care, and minimally invasive procedures such as robotic surgery for gynecologic malignancies.
Dr. Yuan holds a doctorate from Peking Union Medical College and serves as a Chief Physician and Master’s supervisor. Since 2003, Dr. Yuan has worked in gynecologic oncology at the National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, with over twenty years of clinical experience. Dr. Yuan has published more than 20 papers, co-authored multiple monographs, and participated in international multicenter drug clinical trials and national research projects.
Name order: in Chinese the family name comes first (Yuan Guangwen). Papers usually list the name as Guangwen Yuan or Yuan G.
Selected publications
33 papers on PubMed matched by name and affiliation; 10 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Immunother Cancer, 2026 (senior author): Glucose restriction reprograms lipid metabolism and enhances immunotherapy through ZNRF3-Wnt-SCD signaling axis. PubMed 42236114
- Nat Cancer, 2026 (first author): Suvemcitug plus chemotherapy in women with platinum-resistant recurrent ovarian cancer: the SCORES randomized, double-blinded, phase 3 trial. PubMed 41514054
- Gynecol Oncol, 2024 (first author): Suvemcitug plus chemotherapy for platinum-resistant epithelial ovarian, fallopian tube and primary peritoneal cancer: A phase 1b dose-escalation trial. PubMed 38805876
- Eur J Surg Oncol, 2024 (senior author): Outcomes of secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer progressed after prior poly (adenosine diphosphate-ribose) polymerase inhibitors: A retrospective cohort study. PubMed 38704898
- Cells, 2022 (senior author): Prevalence and Prognostic Relevance of Homologous Recombination Repair Gene Mutations in Uterine Serous Carcinoma. PubMed 36428992
- Medicine (Baltimore), 2022 (senior author): Epidemiology of adenosarcoma and the inverse probability of treatment weighting (IPTW) adjusted survival analysis of lymph node dissection in uterine adenosarcoma. PubMed 36197202
- Chin J Cancer Res, 2020 (senior author): Separate lateral parametrial lymph node dissection improves detection rate of parametrial lymph node metastasis in early-stage cervical cancer: 10-year clinical evaluation in a single center in China. PubMed 33447002
- Front Oncol, 2020 (first author): Telomere Maintenance Associated Mutations in the Genetic Landscape of Gynecological Mucosal Melanoma. PubMed 32984050
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion